Literature DB >> 10462065

Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.

V Di Marzo1.   

Abstract

The two putative endogenous ligands of cannabinoid receptors, anandamide and 2-arachidonoylglycerol, are synthesized by and released from neurons in a Ca2+-dependent fashion, and re-uptaken and catabolized by both neurons and astrocytes. These biochemical features of the endocannabinoids, as well as some of their pharmacological effects in both central and peripheral nervous systems, suggest a role as neuromodulators for these metabolites. This neuromodulatory role is supported by the brain regional distribution of anandamide, its biosynthetic precursor and its major inactivating enzyme, and by the existence of possible regulatory mechanisms for the biosynthesis and inactivation of endocannabinoids, which are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462065     DOI: 10.1016/s0024-3205(99)00287-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?

Authors:  C Robin Hiley; William R Ford
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 2.  Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility.

Authors:  Stefan S du Plessis; Ashok Agarwal; Arun Syriac
Journal:  J Assist Reprod Genet       Date:  2015-08-16       Impact factor: 3.412

Review 3.  Polarity scaffolds signaling in epithelial cell permeability.

Authors:  Lauren F O'Leary; Andrea M Tomko; Denis J Dupré
Journal:  Inflamm Res       Date:  2021-03-15       Impact factor: 4.575

4.  Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development.

Authors:  Benjamin M Ford; Lirit N Franks; Sherrica Tai; William E Fantegrossi; Edward L Stahl; Michael D Berquist; Christian V Cabanlong; Catheryn D Wilson; Narsimha R Penthala; Peter A Crooks; Paul L Prather
Journal:  Pharmacol Res       Date:  2017-08-23       Impact factor: 7.658

Review 5.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

6.  Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.

Authors:  Anatol C Kreitzer; Robert C Malenka
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

Review 7.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

8.  Preface to DMR special edition 'Cannabinoid receptors and ligands: therapeutic drug development and abuse potential'.

Authors:  Paul L Prather
Journal:  Drug Metab Rev       Date:  2018-01-30       Impact factor: 4.518

9.  CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.

Authors:  Paola Nieri; Rosamiria Greco; Barbara Adinolfi; Maria Cristina Breschi; Enrica Martinotti; Carla Nannetti; Adriano Podestà
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

Review 10.  Biological functions and metabolism of oleoylethanolamide.

Authors:  Clémentine Thabuis; Delphine Tissot-Favre; Jean-Baptiste Bezelgues; Jean-Charles Martin; Cristina Cruz-Hernandez; Fabiola Dionisi; Frédéric Destaillats
Journal:  Lipids       Date:  2008-08-13       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.